The role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: a systemic review and meta-analysis

医学 肝细胞癌 危险系数 内科学 优势比 置信区间 乙型肝炎 荟萃分析 胃肠病学 子群分析 慢性肝炎 肿瘤科 免疫学 病毒
作者
Qi-Hang Cao,Hui Liu,Lun-Jie Yan,Zi-Niu Ding,Long-Shan Yang,Xin-Chen Mao,Guo-Qiang Pan,Bao-Wen Tian,Chen-Long Han,Zhao-Ru Dong,Dong-Xu Wang,Yu-Chuan Yan,Tao Li
出处
期刊:Research Square - Research Square [Research Square (United States)]
标识
DOI:10.21203/rs.3.rs-3017876/v1
摘要

Abstract Background The purpose of the current study was to investigate the predictive value of hepatitis B core-related antigen (HBcrAg) on the occurrence and recurrence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Methods Based on PubMed, Embase, Scopus, and Web of Science, we conducted a systematic review and meta-analysis of original clinical literature. The primary outcomes were the occurrence and recurrence of HCC assessed by the hazard ratio (HR) or odds ratio (OR) with 95% confidence interval (CI). Results A total of 18 publications with 9039 CHB patients were included in the preliminary analysis. The pooled results suggest that HBcrAg positivity (adjusted HR = 3.10, 95%CI: 2.07–4.64, P < 0.001, I 2 = 62.4%, P = 0.021; OR = 5.65, 95%CI: 3.44–5.82, P < 0.001, I 2 = 0.00%, P = 0.42) was an independent risk factor for the occurrence of HCC. Further subgroup analysis revealed that 4.0 logU/ml may be the optimal cut-off value for HBcrAg to predict the occurrence of HCC. Our meta-analysis also suggests that HBcrAg is a predictor of HCC recurrence during antiviral therapy (adjusted HR = 1.71, 95%CI: 1.26–2.32; I 2 = 78.6%, P = 0.031) and is closely related to recurrence-free survival (RFS) after curative treatment of HCC (P = 0.001). Conclusion For patients with CHB, serum HBcrAg level is closely associated with the occurrence of HCC, regardless of whether nucleoside/nucleotide analogues (NAs) are administered, may also serve as a novel prognostic biomarker of recurrence in HCC. Confirmation of these findings requires more research.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
桐桐的应助被淡淡的冥茗采纳,获得10
1秒前
喝酸奶不要盖儿完成签到,获得积分10
1秒前
1秒前
chenjile发布了新的文献求助10
1秒前
molihuakai的应助被永沐华光采纳,获得10
2秒前
2秒前
2秒前
搜集达人的应助被花紫晴采纳,获得10
2秒前
3秒前
旷野完成签到,获得积分20
3秒前
顺利的冬士完成签到,获得积分10
3秒前
4秒前
4秒前
molihuakai的应助被zhawenchang采纳,获得10
4秒前
4秒前
Hello完成签到 ,获得积分10
4秒前
5秒前
SQC完成签到,获得积分20
5秒前
是群群喽发布了新的文献求助10
5秒前
null的应助被缥缈的芹采纳,获得10
6秒前
6秒前
科研通AI2S的应助被初景采纳,获得10
6秒前
现代的东蒽完成签到,获得积分10
7秒前
7秒前
张伟平完成签到,获得积分10
7秒前
7秒前
卜迷鹿发布了新的文献求助10
7秒前
7秒前
7秒前
8秒前
8秒前
xjc23发布了新的文献求助10
8秒前
所所的应助被keyan采纳,获得10
8秒前
执着尔冬发布了新的文献求助10
8秒前
共享精神的应助被温暖慕山采纳,获得10
8秒前
CodeCraft的应助被斯文盼望采纳,获得10
9秒前
tt发布了新的文献求助10
9秒前
chenjile完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154217
求助须知:如何正确求助?哪些是违规求助? 9550722
关于积分的说明 21700876
捐赠科研通 7743358
什么是DOI,文献DOI怎么找? 3425651
关于科研通互助平台的介绍 2550897
邀请新用户注册赠送积分活动 2469372